Matches in Nanopublications for { ?s ?p "[The O6-methylguanine-DNAmethyltransferase (MGMT) promoter methylation and 1p19q codeletion status can predict sensitivity to chemotherapy and radiation in low- and intermediate-grade gliomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 2 of
2
with 100 items per page.
- assertion description "[The O6-methylguanine-DNAmethyltransferase (MGMT) promoter methylation and 1p19q codeletion status can predict sensitivity to chemotherapy and radiation in low- and intermediate-grade gliomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1267191.RApGUgdqXMi1Hcr7FH_Y6LRHbclJsA3dBGWRcqQRW7_BM130_assertion description "[The O6-methylguanine-DNAmethyltransferase (MGMT) promoter methylation and 1p19q codeletion status can predict sensitivity to chemotherapy and radiation in low- and intermediate-grade gliomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1267191.RApGUgdqXMi1Hcr7FH_Y6LRHbclJsA3dBGWRcqQRW7_BM130_provenance.